Randomized Control Trial of Modified Dingzhenwan Combined with Acupuncture Method of Consciousness Restoration and Resuscitation in Treating with Patients Parkinson's Disease
|更新时间:2024-01-04
|
Randomized Control Trial of Modified Dingzhenwan Combined with Acupuncture Method of Consciousness Restoration and Resuscitation in Treating with Patients Parkinson's Disease
Chinese Journal of Experimental Traditional Medical FormulaeVol. 24, Issue 13, Pages: 190-195(2018)
HUANG Zong-wen, YUAN Yong, GONG Ai-min, et al. Randomized Control Trial of Modified Dingzhenwan Combined with Acupuncture Method of Consciousness Restoration and Resuscitation in Treating with Patients Parkinson's Disease[J]. Chinese journal of experimental traditional medical formulae, 2018, 24(13): 190-195.
DOI:
HUANG Zong-wen, YUAN Yong, GONG Ai-min, et al. Randomized Control Trial of Modified Dingzhenwan Combined with Acupuncture Method of Consciousness Restoration and Resuscitation in Treating with Patients Parkinson's Disease[J]. Chinese journal of experimental traditional medical formulae, 2018, 24(13): 190-195. DOI: 10.13422/j.cnki.syfjx.20181333.
Randomized Control Trial of Modified Dingzhenwan Combined with Acupuncture Method of Consciousness Restoration and Resuscitation in Treating with Patients Parkinson's Disease
Objective: To observe the efficacy of modified Dingzhenwan combined with acupuncture method of consciousness restoration and resuscitation in treating patients with Parkinson's disease (PD)
and investigate its possible mechanism. Method: Eighty-two patients with PD were chosen and randomly divided into control group (41 cases) and treatment group (41 cases) referring to random number table. Both groups orally took levodopa/benserazide dispersible tablet
0.125 g/time
tid. The patients in control group were additionally treated with acupuncture method of consciousness restoration and resuscitation
1 time/day and 6 times/week. On basis of the treatment in control group
the patients in treatment group were additionally treated with Dingzhenwan
1 dose/day and bid. Both groups were treated for 8 weeks. Then the scores of dysfunction of tremor syndrome
symptoms of liver and kidney Yin deficiency syndrome
the Unified PD Rating Scale (UPDRS)
non-motor symptoms questionnaire for Parkinson's disease (NMSQuest)
Parkinson's non-motor symptom rating scale (NMSS) and clinical efficacy were compared between two groups. Serum levels of B cell lymphoma/leukemia 2 (Bcl-2)
Bcl-associated X protein (Bax)
cytochrome C (CytC)
Caspase-9
Caspase-3 and Caspase-6 were detected and compared between these two groups. Result: After treatment
the scores of dysfunction of tremor syndrome
symptoms of liver and kidney deficiency syndrome
UPDRS-Ⅰ
UPDRS-Ⅱand UPDRS-Ⅲ in treatment group were significantly lower than those in control group (P<0.01). As compared to the control group
scores of NMSQuest and NMSS were obviously decreased in treatment group after treatment (P<0.01). Total effective rate was 87.8% in treatment group
higher than 65.85% in control group (P<0.05). After treatment
serum level of Bcl-2 in treatment group was significantly higher
while Bax
Cytc
Caspase-9
Caspase-3 and Caspase-6 levels were significantly lower than those in control group (P<0.01). Conclusion: Based on routine western medicine
Dingzhenwan combined with acupuncture method of consciousness restoration and resuscitation has significant efficacy in treating PD
and the mechanism may be associated with regulating Bcl-2
DIA Proteomics Reveals Mechanism of Acanthopanacis Senticosi Radix et Rhizoma seu Caulis Extract in Treating α-Syn Transgenic Parkinson's Disease in Mice
Treatment of Parkinson's Disease with Traditional Chinese Medicine by Regulating BDNF/TrkB Signaling Pathway: A Review
Clinical Observation of Modified Zhigancao Tang in Treating Patients with Liver and Kidney Deficiency of Parkinson's Disease and Its Effect on Neuronal Signal-related Proteins
Mechanism of Wogonin in Alleviating LPS-Induced Inflammation in BV-2 Cells and Protecting SH-SY5Y Cells
Traditional Chinese Medicine in Treatment of Parkinson's Disease by Regulating TLR4/NF-κB Signaling Pathway: A Review
Related Author
ZHENG Qi
LU Yi
YU Donghua
ZHAO Liangyou
LIN Chunsheng
LU Fang
LIU Shumin
JIA Lulu
Related Institution
Second Affiliated Hospital,Heilongjiang University of Chinese Medicine
Drug Safety Evaluation Centre,Heilongjiang University of Chinese Medicine
Key Laboratory of Modern Preparation of Traditional Chinese Medicine,Ministry of Education,Jiangxi University of Chinese Medicine
Institute of Traditional Chinese Medicine, Heilongjiang University of Chinese Medicine